Carnitine and/or Acetylcarnitine Deficiency as a Cause of Higher Levels of Ammonia

A review of current evidence for acetyl-l-carnitine in the treatment of depression

(2014) Sheng-Min Wang et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Risk Factors of Hyperammonemia in Patients With Epilepsy Under Valproic Acid Therapy

(2014) Yu-Lung Tseng et al.   MEDICINE

Hyperammonemia Associated with Valproic Acid Concentrations

(2014) Marta Vázquez et al.   Biomed Research International

L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors

(2013) C. Nasca et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Carnitine and Acylcarnitines

(2012) Stephanie E. Reuter et al.   CLINICAL PHARMACOKINETICS

Acetyl-l-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy

(2011) Mariano Malaguarnera et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Postictal Transient Hyperammonemia as an Indicator of Seizure Disorder

(2010) Kuan-Ting Liu et al.   EUROPEAN NEUROLOGY

Role of carnitine in disease

(2010) Judith L Flanagan et al.   Nutrition & Metabolism

Mitochondria in the elderly: Is acetylcarnitine a rejuvenator?☆

(2009) Mariana G. Rosca et al.   ADVANCED DRUG DELIVERY REVIEWS

Carnitine in the treatment of valproic acid-induced toxicity

(2009) Philippe E.R. Lheureux et al.   CLINICAL TOXICOLOGY

Acylcarnitines: Role in brain

(2009) Lauren L. Jones et al.   PROGRESS IN LIPID RESEARCH

Acetyl-l-Carnitine Treatment in Minimal Hepatic Encephalopathy

(2008) Mariano Malaguarnera et al.   DIGESTIVE DISEASES AND SCIENCES